Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 39Recruiting 28Terminated 15Active not recruiting 13Unknown 6Not yet recruiting 6Withdrawn 2Suspended 2No longer available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 19Glioma 14Brain Neoplasms 13Astrocytoma 4Neoplasms 3Meningioma 2Gliosarcoma 2Diffuse Intrinsic Pontine Glioma 2Venous Thromboembolism 1Surgical Wound Infection 1Stroke 1Spinal Diseases 1Spinal Cord Neoplasms 1Seizures 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroma 1Neurofibromatosis 1 1Neurofibromatoses 1Neuroblastoma 1Neurilemmoma 1Motor Activity 1Melanoma 1Lymphoma, Follicular 1Liver Neoplasms 1Intracranial Hypertension 1Hydrocephalus 1

Interventions

antineoplaston AS 2-1 1antineoplaston A10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Diffuse Intrinsic Pontine Glioma × CNS × Clear all
NCT02742883 2025-09-16

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Burzynski Research Institute

Phase 2 Suspended
1 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT05123534 2024-09-19

A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG

SonALAsense, Inc.

Phase 2 Suspended
15 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡